<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="surgery" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">422</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2025.50716</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Surgery</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Role of Radiofrequency Ablation in the Management of Benign and Malignant Breast Lesions&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Khadwardi</surname>
            <given-names>Faisal Hasan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Albuqaisi</surname>
            <given-names>Amal Abdullah</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almaqseed</surname>
            <given-names>Mona Adel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alqashqari</surname>
            <given-names>Khairiah Yaqoub</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almalki</surname>
            <given-names>Fahad Hussein</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alenezi</surname>
            <given-names>Meshaal Ibrahim</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alsharif</surname>
            <given-names>Nejoud Faeq</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alghamdi</surname>
            <given-names>Yousef Ahmed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>24</day>
        <month>07</month>
        <year>2025</year>
      </pub-date>
      <volume>5</volume>
      <issue>7</issue>
      <fpage>372</fpage>
      <lpage>381</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The management of breast lesions encompasses a comprehensive clinical spectrum ranging from benign tumors like fibroadenomas to early-stage breast cancer. Conventional treatments, including radiotherapy and surgical excision—continue to be fundamental, although they may cause major morbidity, cosmetic compromise, and psychological discomfort. Recently, there has been an increased interest in image-guided ablation techniques in minimally invasive, organ-preserving therapies. Radiofrequency ablation (RFA) has started to be a reasonable intervention for various breast lesions. Emphasizing its utility, clinical effectiveness, safety, and comparative advantages over other ablative techniques, this review aims to assess the role of RFA in controlling benign and malignant breast diseases. Specific attention is directed toward patient selection criteria, oncological results, aesthetic satisfaction, and modern imaging technology integration. Current studies, particularly in small and well-defined lesions, show that RFA is effective in obtaining high local control rates and patient satisfaction. Current studies, particularly in small and well-defined lesions, show that RFA is effective in obtaining high local control rates and patient satisfaction. Although long-term survival and recurrence data remain limited, RFA may be highly suitable for nonsurgical candidates with early-stage breast cancer. Although RFA has emerged as a promising technique, its integration into clinical practice requires further validation through cost-effectiveness studies and randomized controlled trials. The results support RFA__ampersandsign#39;s prospective application in enhancing customized, minimally invasive intervention for breast lesions.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>radiofrequency</kwd>
        <kwd> radiofrequency ablation</kwd>
        <kwd> RFA</kwd>
        <kwd> benign lesions</kwd>
        <kwd> malignant breast lesions</kwd>
        <kwd> breast lesions</kwd>
        <kwd> breast tumors</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>